These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26497687)

  • 41. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Large B-cell lymphoma with Hodgkin's features.
    García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
    Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
    Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
    Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma.
    Xu Z; Ji J; Xu J; Li D; Shi G; Liu F; Ding L; Ren J; Dou H; Wang T; Hou Y
    FEBS J; 2017 Aug; 284(15):2410-2424. PubMed ID: 28605567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines.
    Cuadros M; Sánchez-Martín V; Herrera A; Baliñas C; Martín-Padrón J; Boyero L; Peinado P; Medina PP
    Clin Transl Oncol; 2017 Aug; 19(8):1010-1017. PubMed ID: 28251496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NGS-Based High-Throughput Screen to Identify MicroRNAs Regulating Growth of B-Cell Lymphoma.
    Kluiver J; Niu F; Yuan Y; Kok K; van den Berg A; Dzikiewicz-Krawczyk A
    Methods Mol Biol; 2019; 1956():269-282. PubMed ID: 30779039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma.
    Lollies A; Hartmann S; Schneider M; Bracht T; Weiß AL; Arnolds J; Klein-Hitpass L; Sitek B; Hansmann ML; Küppers R; Weniger MA
    Leukemia; 2018 Jan; 32(1):92-101. PubMed ID: 28659618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
    Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
    Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma.
    Jia YJ; Liu ZB; Wang WG; Sun CB; Wei P; Yang YL; You MJ; Yu BH; Li XQ; Zhou XY
    Leukemia; 2018 Mar; 32(3):703-711. PubMed ID: 29135973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of cyclin D2 and D3 in lymphoid lesions.
    Teramoto N; Pokrovskaja K; Szekely L; Polack A; Yoshino T; Akagi T; Klein G
    Int J Cancer; 1999 May; 81(4):543-50. PubMed ID: 10225442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance.
    Khare D; Goldschmidt N; Bardugo A; Gur-Wahnon D; Ben-Dov IZ; Avni B
    PLoS One; 2017; 12(11):e0187722. PubMed ID: 29131834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas.
    Zhang Y; Roccaro AM; Rombaoa C; Flores L; Obad S; Fernandes SM; Sacco A; Liu Y; Ngo H; Quang P; Azab AK; Azab F; Maiso P; Reagan M; Brown JR; Thai TH; Kauppinen S; Ghobrial IM
    Blood; 2012 Aug; 120(8):1678-86. PubMed ID: 22797699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-4728 serves as a suppressor and antagonist of oncogenic MAPK in Burkitt lymphoma.
    Wang W; Lin P; Yao H; Jia X; Sun J; Feng L
    Saudi J Biol Sci; 2018 Jul; 25(5):982-985. PubMed ID: 30108451
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significance of the microRNA‑17‑92 gene cluster expressed in B‑cell non‑Hodgkin's lymphoma.
    Yan S; Jia C; Quan L; Zhao L; Tian Y; Liu A
    Mol Med Rep; 2019 Sep; 20(3):2459-2467. PubMed ID: 31322189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elderly Woman With No Autoimmune Disease With Aseptic Meningitis Caused by Celecoxib.
    Takigawa M; Tanaka H; Kobayashi T; Katahara Y; Kinoshita M; Masuda M; Iwakiri R
    Cureus; 2024 Mar; 16(3):e55348. PubMed ID: 38559550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis.
    Yuan Y; Kluiver J; Koerts J; de Jong D; Rutgers B; Abdul Razak FR; Terpstra M; Plaat BE; Nolte IM; Diepstra A; Visser L; Kok K; van den Berg A
    Am J Pathol; 2017 Jun; 187(6):1343-1355. PubMed ID: 28432871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients.
    van Eijndhoven MA; Zijlstra JM; Groenewegen NJ; Drees EE; van Niele S; Baglio SR; Koppers-Lalic D; van der Voorn H; Libregts SF; Wauben MH; de Menezes RX; van Weering JR; Nieuwland R; Visser L; van den Berg A; de Jong D; Pegtel DM
    JCI Insight; 2016 Nov; 1(19):e89631. PubMed ID: 27882350
    [No Abstract]   [Full Text] [Related]  

  • 58. miR-21 expression predicts prognosis in diffuse large B-cell lymphoma.
    Li J; Fu R; Yang L; Tu W
    Int J Clin Exp Pathol; 2015; 8(11):15019-24. PubMed ID: 26823838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis.
    Pan Y; Cengiz R; Kluiver J; Diepstra A; Van den Berg A
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies.
    Stergiou IE; Tsironis C; Papadakos SP; Tsitsilonis OE; Dimopoulos MA; Theocharis S
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.